Rhythm Pharmaceuticals, Inc. RYTM Change in AR
Change in AR at other companies
Other financials
Where this comes from
Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.
The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rhythm Pharmaceuticals, Inc.'s change in ar.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Rhythm Pharmaceuticals, Inc.'s change in AR?
- Rhythm Pharmaceuticals, Inc. (RYTM) reported change in AR of $8.11M in Q1 2026.
- How has Rhythm Pharmaceuticals, Inc.'s change in AR changed year-over-year?
- Rhythm Pharmaceuticals, Inc.'s change in AR increased by 1280.5% year-over-year, from -$687K to $8.11M.
- What does change in AR mean?
- Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.